Kala Visvanathan, MD, on Ovarian Cancer: Lowering Mortality With Lipophilic Statins

August 11, 2020 By The ASCO Post Staff

Kala Visvanathan, MD, of Johns Hopkins Bloomberg School of Public Health, discusses her analysis of data from more than 10,000 women with ovarian cancer. The results suggest that atorvastatin and simvastatin, lipophilic statin cholesterol-lowering drugs, reduced ovarian cancer death rates (Abstract 5782).

Related Content